What is the address of OSTEOSOINS?

The registered office of OSTEOSOINS is located at Chaussée de Namur 78, 1300 Wavre.

Is OSTEOSOINS still active?

Yes. According to the CBE (2 November 2026) OSTEOSOINS is active, legal situation “Normale toestand”, started on 22 October 2007.

Is OSTEOSOINS registered on Peppol?

No, OSTEOSOINS is currently not registered on the Peppol network.

What is the enterprise number of OSTEOSOINS?

The enterprise number of OSTEOSOINS is BE0893118788.

When was OSTEOSOINS founded?

OSTEOSOINS was founded on 22 October 2007.

Is OSTEOSOINS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 October 2007; 5 annual accounts filed, latest fiscal year 2025; 2 events from the Belgian Official Gazette processed.

How much profit did OSTEOSOINS make in 2025?

OSTEOSOINS posted a profit after taxes of € 12,779 in financial year 2025.

What is the revenue of OSTEOSOINS?

As a small company, OSTEOSOINS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 26,174.

OSTEOSOINS (Private Limited) - Wavre - BE0893118788

Dossier OSTEOSOINS, printed on 3 November 2026 from databakkes.be/en/0893118788/osteosoins. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 56 % of short-term debt in 2025; threshold 65 %.
Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

OSTEOSOINS from Wavre, company number BE0893118788, closed financial year 2025 with a result of € 12,779 after tax. For that financial year OSTEOSOINS recorded a gross margin of € 26,174 and equity of € 162,791. Compared with financial year 2024, the result moved from € 14,786 to € 12,779. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 26, 2026.

What it is worth Healthy

€ 162,791

▼ 26% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 12,779

▼ 14% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 44,228

▲ 43% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 70,132 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 3,973

▼ 62% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 2,879

▲ 1% vs 2024

Loans from banks and other lenders, long and short.

Taxes

€ 9,263

▲ 75% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 31,455 Gross margin 2022: € 31,455 First fiscal year in the series	€ 24,103 Gross margin 2023: € 24,103 ▼ 23% vs 2022 (€ 31,455) Unfavourable step	€ 30,988 Gross margin 2024: € 30,988 ▲ 29% vs 2023 (€ 24,103) Favourable step	€ 26,174 Gross margin 2025: € 26,174 ▼ 16% vs 2024 (€ 30,988) Unfavourable step	▼ 16%
Profit after taxes	€ 16,857 Profit after taxes 2022: € 16,857 First fiscal year in the series	€ 8,150 Profit after taxes 2023: € 8,150 ▼ 52% vs 2022 (€ 16,857) Unfavourable step	€ 14,786 Profit after taxes 2024: € 14,786 ▲ 81% vs 2023 (€ 8,150) Favourable step	€ 12,779 Profit after taxes 2025: € 12,779 ▼ 14% vs 2024 (€ 14,786) Unfavourable step	▼ 14%
Equity	€ 197,208 Equity 2022: € 197,208 First fiscal year in the series	€ 205,358 Equity 2023: € 205,358 ▲ 4% vs 2022 (€ 197,208) Favourable step	€ 220,143 Equity 2024: € 220,143 ▲ 7% vs 2023 (€ 205,358) Favourable step	€ 162,791 Equity 2025: € 162,791 ▼ 26% vs 2024 (€ 220,143) Unfavourable step	▼ 26%
Total debts	€ 53,819 Total debts 2022: € 53,819 First fiscal year in the series	€ 42,367 Total debts 2023: € 42,367 ▼ 21% vs 2022 (€ 53,819) Favourable step	€ 29,891 Total debts 2024: € 29,891 ▼ 29% vs 2023 (€ 42,367) Favourable step	€ 96,258 Total debts 2025: € 96,258 ▲ 222% vs 2024 (€ 29,891) Unfavourable step	▲ 222%
Cash	€ 38,078 Cash 2022: € 38,078 First fiscal year in the series	€ 29,019 Cash 2023: € 29,019 ▼ 24% vs 2022 (€ 38,078) Unfavourable step	€ 30,870 Cash 2024: € 30,870 ▲ 6% vs 2023 (€ 29,019) Favourable step	€ 44,228 Cash 2025: € 44,228 ▲ 43% vs 2024 (€ 30,870) Favourable step	▲ 43%
Retained profit	€ 160,008 Retained profit 2022: € 160,008 First fiscal year in the series	€ 168,158 Retained profit 2023: € 168,158 ▲ 5% vs 2022 (€ 160,008) Favourable step	€ 182,943 Retained profit 2024: € 182,943 ▲ 9% vs 2023 (€ 168,158) Favourable step	€ 125,591 Retained profit 2025: € 125,591 ▼ 31% vs 2024 (€ 182,943) Unfavourable step	▼ 31%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 70,132 Dividend 2025: € 70,132 Unchanged (€ 0) Unchanged
Bank debt	€ 3,000 Bank debt 2022: € 3,000 First fiscal year in the series	€ 3,000 Bank debt 2023: € 3,000 Unchanged (€ 3,000) Unchanged	€ 2,837 Bank debt 2024: € 2,837 ▼ 5% vs 2023 (€ 3,000) Favourable step	€ 2,879 Bank debt 2025: € 2,879 ▲ 1% vs 2024 (€ 2,837) Unfavourable step	▲ 1%
Balance sheet total	€ 274,954 Balance sheet total 2022: € 274,954 First fiscal year in the series	€ 271,652 Balance sheet total 2023: € 271,652 ▼ 1% vs 2022 (€ 274,954) Unchanged	€ 273,962 Balance sheet total 2024: € 273,962 ▲ 1% vs 2023 (€ 271,652) Unchanged	€ 281,576 Balance sheet total 2025: € 281,576 ▲ 3% vs 2024 (€ 273,962) Unchanged	▲ 3%

Key figures of OSTEOSOINS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to OSTEOSOINS?

What happened at OSTEOSOINS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 26, 2026 New annual accounts for financial year 2025: profit of € 12,779 (▼ 14% vs 2024). filed late Source: NBB ↗
Nov 22, 2013 Capital increase of € 18,600, published in the Gazette. Source: Staatsblad ↗
Nov 7, 2007 Incorporation, published in the Gazette. Source: Staatsblad ↗

In short

From € 16,857 profit in 2022 to € 12,779 profit in 2025.

Paid € 26,038 in corporate taxes since 2022.

Best year ever: 2022, with € 16,857 profit.

Paid out € 70,132 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Chaussée de Namur 78

1300 Wavre

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Capital increase

22 November 2013 Source: Deed ↗

Luc Jossen(enige vennoot, intekenaar van de kapitaalverhoging) 50%

Incorporation

7 November 2007 Source: Deed ↗

JOSSEN, Luc Léonard Herman Louis(oprichter) 100%

Details

Company number: 0893.118.788
VAT number: BE 0893.118.788
Registered office: Chaussée de Namur 78, 1300 Wavre
Names & denominations: OSTEOSOINS
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 22 October 2007
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗

OSTEOSOINS